Filing Details
- Accession Number:
- 0001127602-10-029875
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-07 17:13:21
- Reporting Period:
- 2010-12-03
- Filing Date:
- 2010-12-07
- Accepted Time:
- 2010-12-07 17:13:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226289 | Eric Craig Schneier | 14 Cambridge Center Cambridge MA 02142 | Evp, Hr, Public Affairs & Comm | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-03 | 1,907 | $44.24 | 23,023 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-03 | 1,907 | $67.20 | 21,116 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-12-07 | 28,093 | $44.24 | 49,209 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-07 | 28,093 | $67.20 | 21,116 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-12-03 | 1,907 | $0.00 | 1,907 | $44.24 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-12-07 | 28,093 | $0.00 | 28,093 | $44.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,093 | 2016-02-05 | No | 4 | M | Direct | |
| 0 | 2016-02-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 460 | Indirect | By Spouse |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Includes 511.6077 shares acquired in Q1 and 22.9231 shares acquired in Q2 2010 under the Biogen Idec Inc. Employee Stock Purchase Plan
- Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
- The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/06/06.
Billionaire Hedge Funds
